LogicBio Therapeutics, Inc. Quarterly Current Ratio in % from Q2 2019 to Q3 2022

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
LogicBio Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q2 2019 to Q3 2022.
  • LogicBio Therapeutics, Inc. Current Ratio for the quarter ending September 30, 2022 was 247 %, a 61.8% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2022 247 -399 -61.8% Sep 30, 2022
Q2 2022 298 -427 -58.9% Jun 30, 2022
Q1 2022 362 -544 -60% Mar 31, 2022
Q4 2021 458 -463 -50.2% Dec 31, 2021
Q3 2021 646 -297 -31.5% Sep 30, 2021
Q2 2021 725 -475 -39.6% Jun 30, 2021
Q1 2021 906 -409 -31.1% Mar 31, 2021
Q4 2020 921 -683 -42.6% Dec 31, 2020
Q3 2020 943 -946 -50.1% Sep 30, 2020
Q2 2020 1.2K -539 -31% Jun 30, 2020
Q1 2020 1.31K Mar 31, 2020
Q4 2019 1.6K Dec 31, 2019
Q3 2019 1.89K Sep 30, 2019
Q2 2019 1.74K Jun 30, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.